跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12,054 条关于
“P2Y12 receptor”
全部
12,054
临床试验
5,785
药物
1,314
机构
30
资讯
4,925
3个月前
LRP5 Protein Identified as Novel Target for Safer Antithrombotic Therapies With Reduced Bleeding Risk
3个月前
CureGene Doses First Participant in U.S. Pivotal Trial of Evategrel, a Novel Dual-Formulation P2Y12 Inhibitor
去年
CureGene's Novel Antiplatelet Therapy CG-0255 Receives Clinical Trial Approval in China
4年前
Myocardial Infarction: Promising Therapies Advance Through Clinical Trials
7个月前
Concept Medical Initiates Global STARS DAPT Trial for Polymer-Free Drug-Eluting Stent in STEMI Patients
3个月前
Vcare PharmaTech's Next-Generation TRK Inhibitor Eratrectinib Wins NMPA Approval for NTRK Fusion-Positive Solid Tumors
去年
P2Y12 Inhibitors Show 23% Reduction in Cardiovascular Events Compared to Aspirin in Post-Stent Patients
3年前
Real-World Study Affirms Palbociclib's Efficacy in Chinese HR+/HER2- Metastatic Breast Cancer Patients
11年前
Palbociclib Plus Letrozole Significantly Extends Progression-Free Survival in ER+ Breast Cancer
去年
Relacorilant Plus Nab-Paclitaxel Shows Promise in Platinum-Resistant Ovarian Cancer
第 1 页,共 493 页
上一页
下一页